CoChat

The innate immune system in Alzheimer's disease

Open access
Boutajangout, Allal, Wisniewski, Thomas · 2013 · International Journal of Cell Biology

The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.

Abstract

Alzheimer's disease (AD) is the leading cause for dementia in the world. It is characterized by two biochemically distinct types of protein aggregates: amyloid β (A β ) peptide in the forms of parenchymal amyloid plaques and congophilic amyloid angiopathy (CAA) and aggregated tau protein in the form of intraneuronal neurofibrillary tangles (NFT). Several risk factors have been discovered that are associated with AD. The most well-known genetic risk factor for late-onset AD is apolipoprotein E4 (ApoE4) (Potter and Wisniewski (2012), and Verghese et al. (2011)). Recently, it has been reported by two groups independently that a rare functional variant (R47H) of TREM2 is associated with the late-onset risk of AD. TREM2 is expressed on myeloid cells including microglia, macrophages, and dendritic cells, as well as osteoclasts. Microglia are a major part of the innate immune system in the CNS and are also involved in stimulating adaptive immunity. Microglia express several Toll-like receptors (TLRs) and are the resident macrophages of the central nervous system (CNS). In this review, we will focus on the recent advances regarding the role of TREM2, as well as the effects of TLRs 4 and 9 on AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2013/576383

Cites

94 of 94 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 6

  1. 10.1001/jamaneurol.2013.579 · DOI · Paper page
  2. 10.1086/342259 · DOI · Paper page
  3. 10.1007/978-3-642-00549-7-8 · doi:10.1007/978-3-642-00549-7-8
  4. 2006, Current Topics in Microbiology and Immunology, 311, 1
  5. 1992, Acta Neuropathologica, 84, 225
  6. 1994, Neuropathology and Applied Neurobiology, 20, 192

Cited by

See all 69

Metadata

Authors
Boutajangout, A., & Wisniewski, T.
Affiliations
  • King Abdulaziz University (SA)
  • Department of Neurology, New York University School of Medicine, Alexandria East River Science Park, 450 East 29th Street, Room 802, New York City, NY 10016, USA
Venue
International Journal of Cell Biology
Publisher
Wiley
Published
2013
Volume
2013
Pages
1-7
ISSN
  • 1687-8876 (ISSN-L)
  • 1687-8884
OpenAlex
W2013165248
Cited by
69
References
93
Citations by year
2026: 3 · 2025: 4 · 2024: 1 · 2023: 4 · 2022: 6 · 2021: 4 · 2020: 5 · 2019: 2 · 2018: 4 · 2017: 4 · 2016: 6 · 2015: 12 · 2014: 14
FWCI
1.04
Type
journal article
Language
en
Open access
Locations
  • International Journal of Cell Biology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institutes of Health (NS073502, AG20245)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, innate immunity, TREM2, microglia, TLR4, TLR9, amyloid-beta, tau protein, neurofibrillary tangles, APOE ε4, myeloid cells, neuroinflammation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.